eNewsletters

    Issue highlights:

    • Events on demand:
      • See the presention from the 2020 Nanion User Group Meeting
      • See the FCDI webinar presentation of a new iCell® Cardiomyocytes2 11713 line and a new protocol for automated arrhythmia detecion
      • See the MaxWell Biosystems presentation on HD-MEA
    • New Publications:
      • Reengineering an Antiarrhythmic Drug Using Patient hiPSC Cardiomyocytes to Improve Therapeutic Potential and Reduce Toxicity
      • Microdose Lithium Reduces Cellular Senescence in Human Astrocytes - A Potential Pharmacotherapy for COVID-19?
      • Mitomycin‐C Treatment during Differentiation of Induced Pluripotent Stem Cell‐derived Dopamine Neurons Reduces Proliferation without Compromising Survival or Function In Vivo

    Issue highlights:

    • Upcoming events:
      • A webinar on high-density microelectrode arrays and their application in Parkinson’s and ALS modeling
      • A webinar on the new iCell® Cardiomyocytes2 launch, and automated detection and classification of arrhythmias
    • FCDI and Axxam form a strategic alliance to provide an integrated platform for advanced drug discovery.
    • New publications highlighting:
      • iCell products to facilitate T cell immunotherapeutics efficacy and safety testing
      • A brain-on-chip model for Parkinson’s disease modeling and therapeutics discovery
      • Electrophysiological characterization and comparison of iCell neuronal cells by HD-MEA

     width=Issue highlights:

    • New publications:
      • See an overview of validation and best practices for using iPSC-derived cardiomyocytes in cardiotox and safety pharmacology
      • iCell DopaNeurons incorporated into a new brain-chip model of the substantia nigra for Parkinson’s disease modeling
    • Upcoming events:
      • The SPS 2020 Virtual Event: See two poster presentations
      • A webinar on the new iCell Cardiomyocytes2 launch, and automated detection and classification of arrhythmias
      • A webinar on high-density microelectrode arrays and their application in Parkinson’s and ALS modeling
    • A new FCDI protocol using Local Extracellular Action Potential (LEAP) for high-sensitivity measurement of ion-channel activity

     width=Issue highlights:

    • See gene expression data for key SARS-CoV-2/COVID-19 targets across all iCell® Products
    • Hydroxychloroquine induces cardiotoxicity in an MEA assay – see the data.
    • Electronic cigarette extract induces toxicity in iCell Cardiomyocytes in an peer-reviewed publication – see the paper.
    • Multiplexed optical sensors are a rich source of cell behavior data in a peer-reviewed study.

     width=Issue highlights:

    • Join us for a microglia disease model webinar
    • Register for an Agilent webinar
    • See presentations from the ISSCR virtual event
    • Career opportunities at FCDI
    • Two new, peer-reviewed publications incorporating deep-learning into research with iCell products